Clinical Trials Using BTK Inhibitor ARQ 531
Clinical trials are research studies that involve people. The clinical trials on this list are studying BTK Inhibitor ARQ 531. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
A Study of ARQ 531 in Patients With Selected Hematologic Malignancies
This is an open-label, multi-center Phase 1 / 2 study of ARQ 531 in patients with selected hematologic malignancies.
Location: 6 locations